安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- MerusCase - Technology for Attorneys
MerusCase intuitively adapts to fit your practice — streamlining document automation, time tracking, billing, calendaring, email, and case management into one easy-to-use system that's accessible anywhere, anytime, from any device
- Pipeline - Merus
Our strategy employs the unique attributes of our proprietary bispecific antibodies and our patented screening technologies to engage and harness the power of the immune system to target tumor cells
- Merus - Dragon Ball Wiki
Merus Ikanoichiyabosshi (メルス・イカノイチヤボッシ, Merusu Ikanoichiyabosshi), formerly just Merus (メルス, Merusu), is the number one elite patrolman of the Galactic Patrol and formerly a Trainee Angel
- Merus | Design-Build Developer, 100% Employee-Owned
Employee-owned, culture-obsessed and career-oriented, Merus is a place where we all grow and succeed together Formerly known as Al Neyer, Merus combines more than 130 years of commercial real estate expertise with an integrated team of company owners
- Merus N. V. (MRUS) Stock Price, News, Quote History - Yahoo . . .
Find the latest Merus N V (MRUS) stock quote, history, news and other vital information to help you with your stock trading and investing
- Merus hails unprecedented survival on solid tumor . . .
Merus has reported a 79% 12-month survival rate in cancer patients on its bispecific antibody, cementing William Blair analysts' belief the candidate has a “best-in-disease profile ”
- Merus’ Bispecific Shows ‘Best in Disease’ Profile in Head-and . . .
Merus’ investigational bispecific antibody petosemtamab, when combined with Merck’s mega-blockbuster Keytruda, led to a nearly 80% overall survival rate when used as a frontline treatment option for certain patients with head and neck cancer, according to a Phase II readout posted Thursday
- MerusCase
© 2008-2023 Merus, Inc Merus™, MerusCase™, and the MerusCase Logo are registered trademarks of Merus, Inc All rights reserved
|
|
|